Literature DB >> 14527171

Tyloxapol attenuates the pathologic effects of endotoxin in rabbits and mortality following cecal ligation and puncture in rats by blockade of endotoxin receptor-ligand interactions.

Vladimir B Serikov1, T V Glazanova, E H Jerome, N W Fleming, Haruki Higashimori, N C Staub.   

Abstract

We have previously demonstrated that the detergent Tyloxapol is effective in preventing reactions to endotoxin. We studied the effects of Tyloxapol on the morbidity and mortality from endotoxemia in rabbits and on the mortality in rats with sepsis. The effects of Tyloxapol on endotoxin binding and macrophage activation were studied in the macrophage cell line RAW264.7 and CHO cells expressing CD14. Isolated human leukocytes were used to study the effects of Tyloxapol on immune reactions, leukocyte motility, and phagocytosis. Intravenous Tyloxapol (200 mg/kg), given prior to or at the time of endotoxin infusion protected rabbits from developing shock. In rats with peritoneal sepsis, a lipid-rich diet and Tyloxapol given at the time of induction of peritonitis protected them from septic death. In vitro, Tyloxapol blocked the binding of endotoxin to murine macrophages and CHO cells expressing CD14, activation of macrophages, and also some antigen-antibody immune reactions (mediated by CD2, CD4, CD22, HLA-DR). Tyloxapol may prevent the reaction to endotoxin by desensitizing endotoxin-recognizing receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527171     DOI: 10.1023/a:1025108207661

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  3 in total

1.  Cytotoxic properties of tyloxapol.

Authors:  Jung-hua Steven Kuo; Ming-shiou Jan; Hsuan Wen Chiu
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

2.  The comparative efficacy of tyloxapol versus pentoxifylline against induced acute phase response in an ovine experimental endotoxemia model.

Authors:  Aliasghar Chalmeh; Alireza Rahmani Shahraki; Seyed Mohammad Mehdi Heidari; Khalil Badiei; Mehrdad Pourjafar; Saeed Nazifi; Mohammad Javad Zamiri
Journal:  Inflammopharmacology       Date:  2015-12-31       Impact factor: 4.473

3.  Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation.

Authors:  Wen Guo; Haijun Li; Yan Lou; Yue Zhang; Jia Wang; Ming Qian; Haifeng Wei; Jianru Xiao; Youjia Xu
Journal:  J Orthop Translat       Date:  2021-04-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.